Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Eckstein

Showing results (1-10 of 261) with videos related to

Pageof 27
Sort By:
Pathologie (Heidelberg, Germany)|November 14, 2025
[NECTIN4 amplification as a predictive biomarker for enfortumab vedotin response]Markus Eckstein
Aktuelle Urologie|February 16, 2026
Markus Eckstein
Urologie (Heidelberg, Germany)|August 4, 2022
[Immunological biomarker research in uro-oncology-using the example of urothelial cancer]Markus Eckstein
European Urology Focus|April 17, 2024
Biomarkers of Response to Anti-NECTIN4 Antibody-Drug Conjugate Enfortumab Vedotin in Urothelial CancerNiklas Klümper, Markus Eckstein
Annals of Translational Medicine|October 3, 2019
New insights in predictive determinants of the tumor immune microenvironment for immune checkpoint inhibition: a never ending story?Markus Eckstein, Shilpa Gupta
European Urology|September 24, 2024
Reply to Feng Qi's Letter to the Editor re: Niklas Klümper, Viktor Grünwald, Arndt Hartmann, et al. The Role of Microsatellite Instability/DNA Mismatch Repair Deficiency and Tumor Mutational Burden as Biomarkers in Predicting Response to Immunotherapy in Castration-resistant Prostate Cancer. Eur Urol. 2024;86:388-390Niklas Klümper, Markus Eckstein
Pathologie (Heidelberg, Germany)|October 31, 2025
[Report of the Uropathology Working Group of the German Society of Pathology]Felix Bremmer, Markus Eckstein
Pathologie (Heidelberg, Germany)|November 12, 2024
[Urinary bladder: tumor precursors and non-invasive carcinoma]Fabienne Lange, Arndt Hartmann, Markus Eckstein
European Urology|January 26, 2023
Reply to Jon Griffin. TIME for a Change? Multimarker Assessment of the Tumour Immune Microenvironment and Metastatic Site Biopsy to Improve Immunotherapy Response Prediction in Muscle-invasive Bladder Cancer. Eur Urol. 2023;43:143-4Niklas Klümper, Michael Hölzel, Markus Eckstein
Aktuelle Urologie|November 27, 2024
[Muscle-invasive and metastatic urothelial carcinoma from a pathological point of view]Niklas Klümper, Charis Kalogirou, Markus Eckstein
Pageof 27

Showing results (1-10 of 261) with videos related to

Sort By:
Pageof 27
Pathologie (Heidelberg, Germany)|November 14, 2025
[NECTIN4 amplification as a predictive biomarker for enfortumab vedotin response]Markus Eckstein
Aktuelle Urologie|February 16, 2026
Markus Eckstein
Urologie (Heidelberg, Germany)|August 4, 2022
[Immunological biomarker research in uro-oncology-using the example of urothelial cancer]Markus Eckstein
European Urology Focus|April 17, 2024
Biomarkers of Response to Anti-NECTIN4 Antibody-Drug Conjugate Enfortumab Vedotin in Urothelial CancerNiklas Klümper, Markus Eckstein
Annals of Translational Medicine|October 3, 2019
New insights in predictive determinants of the tumor immune microenvironment for immune checkpoint inhibition: a never ending story?Markus Eckstein, Shilpa Gupta
European Urology|September 24, 2024
Reply to Feng Qi's Letter to the Editor re: Niklas Klümper, Viktor Grünwald, Arndt Hartmann, et al. The Role of Microsatellite Instability/DNA Mismatch Repair Deficiency and Tumor Mutational Burden as Biomarkers in Predicting Response to Immunotherapy in Castration-resistant Prostate Cancer. Eur Urol. 2024;86:388-390Niklas Klümper, Markus Eckstein
Pathologie (Heidelberg, Germany)|October 31, 2025
[Report of the Uropathology Working Group of the German Society of Pathology]Felix Bremmer, Markus Eckstein
Pathologie (Heidelberg, Germany)|November 12, 2024
[Urinary bladder: tumor precursors and non-invasive carcinoma]Fabienne Lange, Arndt Hartmann, Markus Eckstein
European Urology|January 26, 2023
Reply to Jon Griffin. TIME for a Change? Multimarker Assessment of the Tumour Immune Microenvironment and Metastatic Site Biopsy to Improve Immunotherapy Response Prediction in Muscle-invasive Bladder Cancer. Eur Urol. 2023;43:143-4Niklas Klümper, Michael Hölzel, Markus Eckstein
Aktuelle Urologie|November 27, 2024
[Muscle-invasive and metastatic urothelial carcinoma from a pathological point of view]Niklas Klümper, Charis Kalogirou, Markus Eckstein
Pageof 27